Lupin Limited (BSE: 500257)
Health Care · Pharmaceuticals · IN
Rs2,029.00
-2.92% today · +2.9% 1Y
Lupin Limited (BSE: 500257) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $9.64B.
Over the last twelve months the share price has gained 2.9%, trading between 1.90K and 2.53K.
Tweenvest scores Lupin Limited across four factors: quality 78/100, value 72/100, growth 82/100, dividend 70/100. Its strongest factor is growth.
500257 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $9.64B
- Revenue (TTM)
- $3.17B
- P/E
- 16.81
- EPS
- 120.71
- Dividend yield
- 0.89%
- Beta (5Y)
- 0.17
- 52-week high
- Rs2,530.00
- 52-week low
- Rs1,900.30
- Avg volume (3M)
- —
- Shares outstanding
- 457.23M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Aurobindo Pharma LimitedNSEI: AUROPHARMA | $10.02B | Rs1,676.80 | -2.06% |
| Asymchem Laboratories (Tianjin) Co., Ltd.SZSE: 002821 | $9.93B | CN¥188.62 | +5.79% |
| CSPC Innovation Pharmaceutical Co., Ltd.SZSE: 300765 | $9.80B | CN¥47.19 | +6.89% |
| Sichuan Kelun Pharmaceutical Co., Ltd.SZSE: 002422 | $9.69B | CN¥40.85 | +5.12% |
| Axsome Therapeutics, Inc.NasdaqGM: AXSM | $9.06B | $170.08 | -1.67% |
| Shanghai Fosun Pharmaceutical (Group) Co., Ltd.SHSE: 600196 | $8.79B | CN¥24.02 | +5.17% |
| Krka, d. d.LJSE: KRKG | $8.73B | €257.50 | -0.19% |
| Financière de Tubize SAENXTBR: TUB | $8.51B | €170.80 | +0.65% |
Figures last refreshed Oct 4, 2026.